2Dawson ST.Long-term risk of malignant neoplasm associated with gestational glucose intolerance [J].Cancer,2004,100(1): 149-155.
3Dumontet C,Drai J,Bienvent J.Profiles and prognostic values of LDH isoenzyme in patients with non-Hodgkin's lymphoma [J].Leukemia,1999,13(5):811-817.
4Jurisic V,Konjevic G, Banicevic B,et al.Different alterations in lactic dehydrogenase activity and profile of peripheral blood monenuclear cells in Hodgkin's and non-Hodgkin's lymphoma[J].Eur J Haematol,2000,64(4):259-266.
2Morra E. The biological markers of non-Hodgkin' s lymphomas : their role in diagnosis,prognostic assessment and therapeutic strategy [ J ]. Int J Biol Markers, 1999, 14 ( 3 ) : 149-153.
3Shipp MA, Harrington DP, Anderson JR, et al. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non- Hodgkin's Lymphoma Prognostic Factors Project [ J ] . N Engl Med, 1993, 329 (14) : 987-991.
4Rao RA, Chin K, Pilichowska M, et al. Outcomes in peripheral T-cell lymphoma : Prognosis based on IP1 staging [ J ] . J Clin Oncol,2004, 22 (14) : 6706-6708.
5Montoto S, Lopez-Guillermo A, Ahes A, et al. Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression [ J ] . Ann Oncol, 2004, 15 (10) : 1484-1489.
6Yang L, Xu XH, Peng CL, et al. Prognostic values of serum LDH and β 2-MG in patients with non-Hodgkin's lymphoma [ J ]. Chinese-German J Clin Oncol, 2009, 8 ( 6 ) : 353-355.
